Latest Cancer News

  • Keytruda® Active in Small Cell Lung Cancer 12-27-2016...

    Recently updated findings from the phase 1b KEYNOTE-028 study investigating the use of Keytruda® (pembrolizumab) in small cell lung cancer (SCLC) were recently presented at the 17th World Conference on Lung [...]

  • Rubraca™ Is Granted Accelerated Approval for Advanced Ovarian Cancer 12-20-2016...

    The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Rubraca™ (rucaparib) for the treatment of women with advanced ovarian cancer who have been treated with two or [...]

  • 5-Year Survival Improved with Early Use of Jakafi® in Myelofibrosis 12-20-2016...

    An analysis of 5-year data from two large clinical trials provide conclusive support that treatment with Jakafi® (ruxolitinib) improves long-term survival, compared to other treatment options for patients with myelofibrosis. [...]

  • Tagrisso®: New Standard of Care for Certain Lung Cancer 12-19-2016...

    Treatment with the targeted agent Tagrisso (osimertinib) significantly delayed cancer progression, and resulted in fewer side effects, than standard chemotherapy for patients with advanced non-small cell lung cancer (NSCLC) whose [...]